Enliven Therapeutics
ELVN
#3751
Rank
NZ$6.25 B
Marketcap
NZ$84.96
Share price
0.26%
Change (1 day)
119.15%
Change (1 year)

EPS for Enliven Therapeutics (ELVN)

EPS in 2026 (TTM): NZ-$2.90

According to Enliven Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$3.05. In 2025 the company made an earnings per share (EPS) of NZ-$3.40 an increase over its 2024 EPS that were of NZ-$3.45.

EPS history for Enliven Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.90-14.48%
2025NZ-$3.40-1.59%
2024NZ-$3.45